Lupin Ltd.

₹2,095

17.2 (0.8%)

LUPIN Share Price

Pharmaceuticals & Biotechnology

As on September 11, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 95,689 Cr

P/E Ratio17.96

Dividend Yield0.43 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,096.5	Bearish
10-DMA	2,122.11	Bearish
20-DMA	2,160.93	Bearish
50-DMA	2,311.96	Bearish
100-DMA	2,311.38	Bearish
200-DMA	2,256.28	Bearish

Historical Performance

1 Year

5.4%

3 Years

86%

5 Years

113.4%

10 Years

33.5%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	2,79,580	2,27,079	2,00,108	1,66,417	1,64,055
Total Expenditure	1,97,985	1,74,304	1,62,217	1,49,211	1,61,902
Other Income	10,809	2,016	1,416	1,509	2,137
Operating Profit	92,404	54,791	39,307	18,715	4,289
Interest	4,345	2,949	3,116	2,743	1,428
Depreciation	13,755	11,693	11,968	8,807	16,587
Profit Before Tax	68,726	40,150	24,223	7,165	-13,722
Consolidated Net Profit	53,328	32,816	19,145	4,301	-15,280
Adjusted EPS	117	72	42	9	-34

Compounded Sales Growth

10 Years:14.6

5 Years:13

3 Years:10.9

TTM:4.2

Compounded Profit Growth

10 Years:18.7

5 Years:34.4

3 Years:65.5

TTM:10.2

Stock Price CAGR

10 Years:3.2

5 Years:16.3

3 Years:21.9

TTM:2.5

Return on Equity

10 Years:56.6

5 Years:-33.6

3 Years:42

last year:116.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	914	913	911	910	909
Total Reserves	2,22,926	1,70,282	1,40,847	1,22,246	1,19,006
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	26,355	23,900	8,197	9,921	11,531
Other Current Liabilities	33,000	22,743	19,194	15,772	13,941
Short Term Borrowings	39,488	30,156	26,699	42,165	37,023
Total Liabilities	3,78,001	2,86,458	2,36,946	2,28,003	2,16,515
Capital Work in Progress	6,952	3,554	5,957	8,948	8,475
Long Term Loans & Advances	3,018	3,078	3,206	6,209	5,724
Currents Investments	35,771	10,591	8,469	4,398	8,224
Short Term Loans and Advances	4,397	3,126	3,242	2,260	11,469
Total Current Assets	2,40,274	1,67,986	1,34,476	1,24,513	1,24,577
Total Assets	3,78,001	2,86,458	2,36,946	2,28,003	2,16,515
Adjusted Book Value	490	375	311	271	264

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 17.96, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a strong 3-year price CAGR of 22.3%, indicating sustained price appreciation.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹92404 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹279580 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1023949.2

No. of Shares: 489 (Approx)

Performance:2.4%

23949.2

NIFTY Performance: -6.8%

1 day Top Gainers